Document And Entity Information
Document And Entity Information - USD ($) | 12 Months Ended | ||
Mar. 31, 2023 | Sep. 01, 2023 | Sep. 30, 2022 | |
Document Information Line Items | |||
Entity Registrant Name | REST EZ, INC. | ||
Document Type | 10-K | ||
Current Fiscal Year End Date | --03-31 | ||
Entity Common Stock, Shares Outstanding | 20,000,000 | ||
Entity Public Float | $ 80,000 | ||
Amendment Flag | false | ||
Entity Central Index Key | 0001733861 | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Non-accelerated Filer | ||
Entity Well-known Seasoned Issuer | No | ||
Document Period End Date | Mar. 31, 2023 | ||
Document Fiscal Year Focus | 2023 | ||
Document Fiscal Period Focus | FY | ||
Entity Small Business | true | ||
Entity Emerging Growth Company | true | ||
Entity Shell Company | false | ||
Entity Ex Transition Period | false | ||
ICFR Auditor Attestation Flag | false | ||
Document Annual Report | true | ||
Document Transition Report | false | ||
Entity File Number | 333-256498 | ||
Entity Incorporation, State or Country Code | WY | ||
Entity Tax Identification Number | 82-4268982 | ||
Entity Address, Address Line One | 1398 W. Mason Hollow Dr. | ||
Entity Address, City or Town | Riverton | ||
Entity Address, State or Province | UT | ||
Entity Address, Postal Zip Code | 84065 | ||
City Area Code | (801) | ||
Local Phone Number | 300-2542 | ||
Title of 12(b) Security | None | ||
No Trading Symbol Flag | true | ||
Security Exchange Name | NONE | ||
Entity Interactive Data Current | Yes | ||
Document Financial Statement Error Correction [Flag] | false | ||
Auditor Firm ID | 2738 | ||
Auditor Name | M&K CPAS, PLLC | ||
Auditor Location | Houston, TX |
BALANCE SHEETS
BALANCE SHEETS - USD ($) | Mar. 31, 2023 | Mar. 31, 2022 |
Current assets | ||
Cash | $ 44 | $ 431 |
Deposits | 0 | 405,000 |
Inventory | 2,550 | 2,550 |
Total Current Assets | 2,594 | 407,981 |
Total Assets | 2,594 | 407,981 |
Current liabilities | ||
Accounts payable | 96 | 0 |
Income taxes payable | 41,687 | 41,687 |
Total current liabilities | 173,158 | 160,137 |
Stockholders' equity | ||
Common stock, $0.001 par value, 100,000,000 shares authorized, 20,000,000 shares issued and outstanding as of March 31, 2023 and 2022 | 20,000 | 20,000 |
Additional paid-in capital | 121,589 | 111,291 |
Retained earnings | (312,153) | 116,553 |
Total stockholders' equity | (170,564) | 247,844 |
Total liabilities and stockholders' equity | 2,594 | 407,981 |
Related Party [Member] | ||
Current liabilities | ||
Loan from related party | $ 131,375 | $ 118,450 |
BALANCE SHEETS (Parentheticals)
BALANCE SHEETS (Parentheticals) - $ / shares | Mar. 31, 2023 | Mar. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in Dollars per share) | $ 0.001 | $ 0.001 |
Common stock, shares issued | 20,000,000 | 20,000,000 |
Common stock, shares outstanding | 20,000,000 | 20,000,000 |
Common stock, shares authorized | 100,000,000 | 100,000,000 |
STATEMENTS OF OPERATIONS
STATEMENTS OF OPERATIONS - USD ($) | 12 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue | $ 0 | $ 519,443 |
Cost of goods sold | 0 | 269,050 |
Gross profit | 0 | 250,393 |
Operating expenses: | ||
General and administrative | 13,408 | 26,751 |
Impairment of vendor deposit | 405,000 | 0 |
Total operating expenses | 418,408 | 26,751 |
Net operating income (loss) | (418,408) | 223,642 |
Other income (expense): | ||
Interest expense | (10,298) | (9,984) |
Total other expense | (10,298) | (9,984) |
Income (loss) before provision for income taxes | (428,706) | 213,658 |
Provision for income taxes | 0 | (41,687) |
Net income (loss) | $ (428,706) | $ 171,971 |
Net income (loss) per share - basic (in Dollars per share) | $ (0.02) | $ 0.01 |
Net income (loss) per share - diluted (in Dollars per share) | $ (0.02) | $ 0.01 |
Weighted average shares outstanding - basic (in Shares) | 20,000,000 | 20,000,000 |
Weighted average shares outstanding - diluted (in Shares) | 20,000,000 | 20,000,000 |
STATEMENTS OF CASH FLOWS
STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
CASH FLOWS FROM OPERATING ACTIVITIES | ||
Net income (loss) | $ (428,706) | $ 171,971 |
Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
Imputed interest on related party loan | 10,298 | 9,984 |
Impairment of vendor deposit | 405,000 | 0 |
Changes in assets and liabilities: | ||
Deposits | 0 | (324,850) |
Inventory | 0 | 23,900 |
Accounts payable | 96 | 0 |
Income tax payable | 0 | 41,687 |
Net cash used in operating activities | (13,312) | (77,308) |
CASH FLOWS FROM FINANCING ACTIVITIES | ||
Proceeds from contributed capital | 0 | 80,000 |
Repayments of related party debt | (6) | (23,525) |
Proceeds from related party debt | 12,931 | 8,914 |
Net cash provided by financing activities | 12,925 | 65,389 |
Net decrease in cash and cash equivalents | (387) | (11,919) |
Cash and cash equivalents at beginning of period | 431 | 12,350 |
Cash and cash equivalents at end of period | 44 | 431 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
Interest paid | 0 | 0 |
Income taxes paid | $ 0 | $ 0 |
STATEMENT OF CHANGES IN STOCKHO
STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | Total |
Balance at Mar. 31, 2021 | $ 20,000 | $ 21,307 | $ (55,418) | $ (14,111) |
Balance (in Shares) at Mar. 31, 2021 | 20,000,000 | |||
Imputed interest on related party loan | 9,984 | 9,984 | ||
Proceeds from contributed capital | 80,000 | 80,000 | ||
Net income (loss) | 171,971 | 171,971 | ||
Balance at Mar. 31, 2022 | $ 20,000 | 111,291 | 116,553 | $ 247,844 |
Balance (in Shares) at Mar. 31, 2022 | 20,000,000 | 20,000,000 | ||
Imputed interest on related party loan | 10,298 | $ 10,298 | ||
Proceeds from contributed capital | 0 | |||
Net income (loss) | (428,706) | (428,706) | ||
Balance at Mar. 31, 2023 | $ 20,000 | $ 121,589 | $ (312,153) | $ (170,564) |
Balance (in Shares) at Mar. 31, 2023 | 20,000,000 | 20,000,000 |
General Organization and Busine
General Organization and Business | 12 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | Note 1. General Organization and Business Rest EZ, Inc. (the “Company”) was incorporated on October 17, 2016. The Company has passed through all stages of development to full operations from incorporation, at the present time the company is currently in full Production and Distribution to wholesalers and retailers as well as online at www.RestEz.net. Rest EZ Inc. has commenced its major operations of having one product a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider (Sport Energy) that manufactures liquid gels to various Companies, but has not distributed this product to anyone except Rest EZ Inc. The Company’s year-end is March 31. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 12 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | Note 2. Summary of Significant Accounting Policies Basis of Presentation The financial statements have been prepared in accordance with United States generally accepted accounting principles and reflect all adjustments which, in the opinion of management, are necessary for a fair presentation. All such adjustments are of a normal recurring nature. Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period between the origination of these instruments and their expected realization. FASB Accounting Standards Codification (ASC) 820 Fair Value Measurements and Disclosures Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 - Inputs that are both significant to the fair value measurement and unobservable. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash and accrued expenses reported on the balance sheet are estimated by management to approximate fair value primarily due to the short-term nature of the instruments. The Company had no items that required fair value measurement on a recurring basis. Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. At March 31, 2023 and 2022, there were no dilutive securities excluded from the calculation of fully-diluted loss per share because the effect would have been anti-dilutive. Cash and Cash Equivalents All cash is maintained with a major financial institution in the United States. Deposits with this bank may occasionally exceed the amount of insurance provided on such deposits. For the purpose of the financial statements, cash includes cash in banks. Cash was $44 and $431 as of March 31, 2023 and 2022, respectively. There were no cash equivalents as of March 31, 2023 and 2022. The Federal Deposit Insurance Corporation (“FDIC”) insures these balances up to $250,000. At March 31, 2023 and 2022, cash in excess of the insured amount was $0. Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and deposits on inventory. The Company places its cash in quality financial institutions; at times, such investments may be in excess of applicable government mandated insurance limit. During the year March 31, 2022, one customer accounted for 100% of the Company’s total sales. Stock-Based Compensation As of March 31, 2023, the Company has not issued any stock-based payments to its employees. Stock-based compensation is accounted for at fair value in accordance with ASC 718, when applicable. To date, the Company has not adopted a stock option plan and has not granted any stock options. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes Revenue Recognition The Company recognizes revenue from product sales upon product delivery. All of our products are shipped through a third-party fulfillment center to the customer and the customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues. Deferred revenue recorded on the balance sheet represents payments received by the Company in advance of the product being delivered. We adopted ASC Topic 606, “Revenue from Contracts with Customers”, and all related interpretations for recognition of our revenue. Under ASC 606, the Company recognizes revenue from the commercial sales of products by applying the following steps: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to each performance obligation in the contract; and (5) recognizing revenue when each performance obligation is satisfied. There was no revenue during the year ended March 31, 2023; all revenue during the year ended March 31, 2022 was from product sales. Inventories Inventories are stated at the lower of cost or net realizable value, using the first-in, first-out method. The Company reviews its inventory for obsolescence and any inventory identified as obsolete is reserved or written off. The Company’s determination of obsolescence is based on assumptions about the demand for its products, product expiration dates, estimated future sales, and management’s future plans. Commitments and Contingencies The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. There are no known commitments or contingencies as of March 31, 2023 and 2022. Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption. There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on our consolidated financial position, results of operations or cash flows. |
Going Concern
Going Concern | 12 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Substantial Doubt about Going Concern [Text Block] | Note 3. Going Concern The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. For the year ended March 31, 2023, the Company had a net loss of $428,706. As of March 31, 2023, the Company had a working capital deficit of $170,564 and an accumulated deficit of $312,153. The Company’s sales have all been from one customer. Without additional capital and without increasing its customer base, the Company may not be able to remain in business. These factors raise a substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern. Achievement of Rest EZ, Inc.’s business objective is basically dependent upon the judgment, skill and knowledge the Company’s management. Mr. Sosa is currently the Company’s sole executive officer and director. There can be no assurance that a suitable replacement could be found for our sole executive officer and director upon his retirement, resignation, inability to act on our behalf, or death. |
Deposits
Deposits | 12 Months Ended |
Mar. 31, 2023 | |
Disclosure Text Block Supplement [Abstract] | |
Other Assets Disclosure [Text Block] | Note 4. Deposits The Company deposits funds with its supplier in advance of inventory purchases. During the year ended March 31, 2023, the Company impaired the vendor deposit in the amount of $405,000 on inventory. The inventory is in partial production, however, the manufacturer is awaiting an ingredient that has not been available and may not become available. The Company impaired the deposit amount because it is unsure whether the inventory will be received. Because the inventory is in partial production, the Company is unable to obtain a refund of the deposit amount. The amount of outstanding deposits at March 31, 2023 and 2022 was $0 and $405,000, respectively. |
Inventory
Inventory | 12 Months Ended |
Mar. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Inventory Disclosure [Text Block] | Note 5. Inventory Inventory consists of one product, a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider. At March 31, 2023 and 2022, inventory consisted of the following: March 31, 2023 March 31, 2022 Finished Goods Inventory $ 2,550 $ 2,550 |
Loan from Related Party
Loan from Related Party | 12 Months Ended |
Mar. 31, 2023 | |
Debt Disclosure [Abstract] | |
Debt Disclosure [Text Block] | Note 6. Loan from Related Party As of March 31, 2023, Brandon Sosa, President and sole shareholder of the Company, had loaned the Company the amount of $131,375, net of repayments of $35,214. During the year ended March 31, 2023, the Company received funds in the amount of $12,931 and made repayments in the amount $6 on this loan. As of March 31, 2022, Mr. Sosa had loaned the Company funds for operating capital the amount of $118,450, net of repayments of $35,208. During the year ended March 31, 2022, the Company received funds in the amount of $8,914 and made repayments in the amount $23,525 on this loan. The Company imputed interest on this loan at the rate of 8% per year. During the years ended March 31, 2023 and 2022, the Company recorded interest in the amount of $10,298 and $9,984, respectively, on this loan and charged these amounts to additional paid-in capital. |
Stockholders' Equity
Stockholders' Equity | 12 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Equity [Text Block] | Note 7. Stockholders Equity The Company has 100,000,000 authorized shares of common stock with $0.001 par value. As of March 31, 2023 and 2022, there were 20,000,000 shares of common stock outstanding. During the years ended March 31, 2023 and 2022, the Company charged the amounts of $10,298 and $9,984 respectively, to additional paid-in capital pursuant to a loan from the Company’s President. See note 6. On May 26, 2021, the Company filed a Form S-1 with the Securities Exchange Commission in order to register the Company’s currently outstanding 20,000,000 shares of common stock. This registration statement became effective on July 19, 2021. During the year ended March 31, 2022, Brandon Sosa, the Company’s founder and CEO, sold 8,000,000 shares of common stock he personally owned to outside investors at a price of $0.01 per share. Proceeds in the net amount of $80,000 were contributed to the Company, and are recorded as contributed capital on the Company’s statement of stockholder’s equity (deficit) at March 31, 2022. Previous to this sale of shares, Mr. Sosa owned 20,000,000 shares of the Company’s common stock; subsequent to this sale of shares, Mr. Sosa owned 12,000,000 shares of the Company’s common stock. |
Income Taxes
Income Taxes | 12 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | Note 8. Income Taxes There is no current or deferred income tax expense or benefit for the period ended March 31, 2023 and 2022. The Company accounts for income taxes under FASB ASC 740-10, which provides for an asset and liability approach of accounting for income taxes. Under this approach, deferred tax assets and liabilities are recognized based on anticipated future tax consequences, using currently enacted tax laws, attributed to temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts calculated for income tax purposes. The components of the income tax provision include: Year ended March 31, 2023 2022 Net income (loss) (428,706 ) 213,658 Effective tax rate 26 % 26 % Tax at statutory rate (111,464 ) 55,551 Change in valuation allowance 111,464 (13,864 ) Provision for income tax - 41,687 At March 31, 2023 and 2022, the Company had a net operating loss carryforward in the amount of $268,370 and $0, respectively. The Company has recorded a liability for income taxes payable in the amount of $41,687. |
Related Party Transactions
Related Party Transactions | 12 Months Ended |
Mar. 31, 2022 | |
Related Party Transactions [Abstract] | |
Related Party Transactions Disclosure [Text Block] | Note 9. Related Party Transactions The Company uses a corporate office located at: 1398 W. Mason Hollow Drive, Riverton, Utah 84065. This facility is being provided to the Company free of charge by the Company’s CEO. See notes 6 and 7 for disclosure of additional related party transactions. |
Subsequent Events
Subsequent Events | 12 Months Ended |
Mar. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | Note 10. Subsequent Events The Company has evaluated events occurring subsequent to March 31, 2023 through the date these financial statements were issued and noted no items requiring disclosure. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 12 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation The financial statements have been prepared in accordance with United States generally accepted accounting principles and reflect all adjustments which, in the opinion of management, are necessary for a fair presentation. All such adjustments are of a normal recurring nature. |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. |
Fair Value of Financial Instruments, Policy [Policy Text Block] | Fair Value of Financial Instruments The Company’s balance sheet includes certain financial instruments. The carrying amounts of current assets and current liabilities approximate their fair value because of the relatively short period between the origination of these instruments and their expected realization. FASB Accounting Standards Codification (ASC) 820 Fair Value Measurements and Disclosures Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. Level 3 - Inputs that are both significant to the fair value measurement and unobservable. The adoption of this standard did not have a material effect on the Company’s financial statements as reflected herein. The carrying amounts of cash and accrued expenses reported on the balance sheet are estimated by management to approximate fair value primarily due to the short-term nature of the instruments. The Company had no items that required fair value measurement on a recurring basis. |
Earnings Per Share, Policy [Policy Text Block] | Basic and Diluted Loss Per Share Basic loss per share is computed by dividing net loss available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. At March 31, 2023 and 2022, there were no dilutive securities excluded from the calculation of fully-diluted loss per share because the effect would have been anti-dilutive. |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash and Cash Equivalents All cash is maintained with a major financial institution in the United States. Deposits with this bank may occasionally exceed the amount of insurance provided on such deposits. For the purpose of the financial statements, cash includes cash in banks. Cash was $44 and $431 as of March 31, 2023 and 2022, respectively. There were no cash equivalents as of March 31, 2023 and 2022. The Federal Deposit Insurance Corporation (“FDIC”) insures these balances up to $250,000. At March 31, 2023 and 2022, cash in excess of the insured amount was $0. |
Concentration Risk, Credit Risk, Policy [Policy Text Block] | Concentrations of Credit Risk Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash, cash equivalents and deposits on inventory. The Company places its cash in quality financial institutions; at times, such investments may be in excess of applicable government mandated insurance limit. During the year March 31, 2022, one customer accounted for 100% of the Company’s total sales. |
Share-Based Payment Arrangement [Policy Text Block] | Stock-Based Compensation As of March 31, 2023, the Company has not issued any stock-based payments to its employees. Stock-based compensation is accounted for at fair value in accordance with ASC 718, when applicable. To date, the Company has not adopted a stock option plan and has not granted any stock options. |
Income Tax, Policy [Policy Text Block] | Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes |
Revenue [Policy Text Block] | Revenue Recognition The Company recognizes revenue from product sales upon product delivery. All of our products are shipped through a third-party fulfillment center to the customer and the customer takes title to product and assumes risk and ownership of the product when it is delivered. Shipping charges to customers and sales taxes collectible from customers, if any, are included in revenues. Deferred revenue recorded on the balance sheet represents payments received by the Company in advance of the product being delivered. We adopted ASC Topic 606, “Revenue from Contracts with Customers”, and all related interpretations for recognition of our revenue. Under ASC 606, the Company recognizes revenue from the commercial sales of products by applying the following steps: (1) identifying the contract with a customer; (2) identifying the performance obligations in the contract; (3) determining the transaction price; (4) allocating the transaction price to each performance obligation in the contract; and (5) recognizing revenue when each performance obligation is satisfied. There was no revenue during the year ended March 31, 2023; all revenue during the year ended March 31, 2022 was from product sales. |
Inventory, Policy [Policy Text Block] | Inventories Inventories are stated at the lower of cost or net realizable value, using the first-in, first-out method. The Company reviews its inventory for obsolescence and any inventory identified as obsolete is reserved or written off. The Company’s determination of obsolescence is based on assumptions about the demand for its products, product expiration dates, estimated future sales, and management’s future plans. |
Commitments and Contingencies, Policy [Policy Text Block] | Commitments and Contingencies The Company follows subtopic 450-20 of the FASB Accounting Standards Codification to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. There are no known commitments or contingencies as of March 31, 2023 and 2022. |
New Accounting Pronouncements, Policy [Policy Text Block] | Recently Issued Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies that the Company adopts as of the specified effective date. Unless otherwise discussed, the Company does not believe that the impact of recently issued standards that are not yet effective will have a material impact on the Company’s financial position or results of operations upon adoption. There are various other updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on our consolidated financial position, results of operations or cash flows. |
Inventory (Tables)
Inventory (Tables) | 12 Months Ended |
Mar. 31, 2023 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory, Current [Table Text Block] | Inventory consists of one product, a liquid gel capsule named Rest EZ Sleep Aid Supplement, manufactured by an unaffiliated outside provider. At March 31, 2023 and 2022, inventory consisted of the following: March 31, 2023 March 31, 2022 Finished Goods Inventory $ 2,550 $ 2,550 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Mar. 31, 2023 | |
Income Tax Disclosure [Abstract] | |
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] | The components of the income tax provision include: Year ended March 31, 2023 2022 Net income (loss) (428,706 ) 213,658 Effective tax rate 26 % 26 % Tax at statutory rate (111,464 ) 55,551 Change in valuation allowance 111,464 (13,864 ) Provision for income tax - 41,687 |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2022 | Mar. 31, 2023 | |
Summary of Significant Accounting Policies (Details) [Line Items] | ||
Cash and Cash Equivalents, at Carrying Value | $ 431 | $ 44 |
Cash, FDIC Insured Amount | 250,000 | |
Cash, Uninsured Amount | $ 0 | |
Credit Concentration Risk [Member] | Revenue Benchmark [Member] | ||
Summary of Significant Accounting Policies (Details) [Line Items] | ||
Concentration Risk, Customer | one customer | |
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | ||
Summary of Significant Accounting Policies (Details) [Line Items] | ||
Concentration Risk, Percentage | 100% |
Going Concern (Details)
Going Concern (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Net Income (Loss) Attributable to Parent | $ (428,706) | $ 171,971 |
Working Capital (Deficit) | 170,564 | |
Retained Earnings (Accumulated Deficit) | $ (312,153) | $ 116,553 |
Deposits (Details)
Deposits (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Disclosure Text Block Supplement [Abstract] | ||
Asset Impairment Charges | $ 405,000 | $ 0 |
Deposit Assets | $ 0 | $ 405,000 |
Inventory (Details) - Schedule
Inventory (Details) - Schedule of Inventory, Current - USD ($) | Mar. 31, 2023 | Mar. 31, 2022 |
Schedule Of Inventory Current Abstract | ||
Finished Goods Inventory | $ 2,550 | $ 2,550 |
Loan from Related Party (Detail
Loan from Related Party (Details) - USD ($) | 12 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Loan from Related Party (Details) [Line Items] | ||
Proceeds from Related Party Debt | $ 12,931 | $ 8,914 |
Imputed Interest, Interest Rate, Percentage | 8% | |
Imputed Interest | 10,298 | $ 9,984 |
Chief Executive Officer [Member] | ||
Loan from Related Party (Details) [Line Items] | ||
Repayments of Related Party Debt | 6 | 23,525 |
Proceeds from Related Party Debt | 12,931 | 8,914 |
Chief Executive Officer [Member] | ||
Loan from Related Party (Details) [Line Items] | ||
Loans Payable | 131,375 | 118,450 |
Repayments of Related Party Debt | $ 35,214 | $ 35,208 |
Stockholders' Equity (Details)
Stockholders' Equity (Details) - USD ($) | 12 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | Oct. 17, 2016 | |
Stockholders' Equity (Details) [Line Items] | |||
Common Stock, Shares Authorized | 100,000,000 | 100,000,000 | |
Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.001 | $ 0.001 | |
Common Stock, Shares, Outstanding | 20,000,000 | 20,000,000 | |
Imputed Interest (in Dollars) | $ 10,298 | $ 9,984 | |
Sale of Stock, Number of Shares Issued in Transaction | 8,000,000 | ||
Sale of Stock, Price Per Share (in Dollars per share) | $ 0.01 | ||
Proceeds from Contributed Capital (in Dollars) | $ 0 | $ 80,000 | |
Chief Executive Officer [Member] | |||
Stockholders' Equity (Details) [Line Items] | |||
Investment Owned, Balance, Shares | 12,000,000 | 20,000,000 |
Income Taxes (Details)
Income Taxes (Details) - USD ($) | Mar. 31, 2023 | Mar. 31, 2022 |
Income Tax Disclosure [Abstract] | ||
Operating Loss Carryforwards | $ 268,370 | $ 0 |
Accrued Income Taxes, Current | $ 41,687 |
Income Taxes (Details) - Schedu
Income Taxes (Details) - Schedule of Effective Income Tax Rate Reconciliation - USD ($) | 12 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Schedule Of Effective Income Tax Rate Reconciliation Abstract | ||
Net income (loss) | $ (428,706) | $ 213,658 |
Effective tax rate | 26% | 26% |
Tax at statutory rate | $ (111,464) | $ 55,551 |
Change in valuation allowance | 111,464 | (13,864) |
Provision for income tax | $ 0 | $ 41,687 |